Muhammad Bilal, Muhammad Ahad Sher Khan, Abdul Haseeb.
Intracoronary infusion of Wharton`s jelly-derived mesenchymal stem cells: a novel treatment in patients of acute myocardial infarction.
J Pak Med Assoc Jan ;65(12):1369-1369.

Madam, the substantial loss of cardiomyocytes as a result of an acute myocardial infarction (MI), eventually leads to ischaemic heart failure, with the forefront cause being coronary artery disease. The morbidity and mortality rates have been speculated to show improvement with further advancements in techniques to treat the damage. One such improvement has been seen with the development and use of Wharton's jelly-derived mesenchymal stem cells (WJMSCs) to treat acute MI. These particular stem cells have been detached from the sub-amnion to the perivascular region of the umbilical cord, with its origin being extra-embryonic or embryonic mesoderm.1 WJMSCs differentiate into cardiomyocytes and combine with the ischaemic cardiac tissues which helps to improve cardiac function.2

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com